Hepatitis Companies in BioPortfolio's Corporate Database
Hepatitis company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Hepatitis companies that have been added to our website.
Search For More Hepatitis Companies
If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Hepatitis Companies.
More Information about Hepatitis on BioPortfolio
We have published hundreds of Hepatitis news stories on BioPortfolio along with dozens of Hepatitis Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Hepatitis for you to read.
Showing "hepatitis hepatitides" Companies 1 to 25 of 119
Enanta Phatmaceuticals ARE A RESEARCH AND DEVELOPMENT-FOCUSED BIOTECHNOLOGY COMPANY that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field. Enanta are discovering and developing novel inhibitors designed for use against the hepatitis C virus, or HCV. These inhibitors include members of the direct acting antivi...
The International Society for Interferon and Cytokine Research (ISICR), based in Bethesda, Md., is a non-profit organization devoted to interferon, cytokine and chemokine research in the fields of cell biology, molecular biology, biochemistry, and pre-clinical and clinical drug development. The ISICR provides a forum for sharing knowledge and encourages...
Profectus BioSciences, Inc. is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases with a goal of reducing morbidity and mortality. Since its inception in 2003, the Companyâs strategic intent has been to develop and acquire the technologies needed to deliver on that mission within high value mark...
Okairos is a clinical-stage biopharmaceutical company, developing genetic vaccines for major infectious diseases - including malaria, hepatitis C, influenza, respiratory syncytial virus and cancer - using a novel proprietary technology. The company is headquartered in Basel, Switzerland and has laboratories in Rome and Naples, Italy.
Univec, Inc., a minority business enterprise (MBE), is a Specialty Pharmaceutical Company that manufactures and distributes high cost Specialty Pharmaceuticals. Specialty Pharmaceuticals are high cost products that are not usually dispensed in retail pharmacies but require special handling and a complex pharmaceutical regime. The company is focused on dise...
Transgene (NYSE-Euronext: TNG), a member of the Institut Mérieux Group, is a biopharmaceutical company. It creates, develops and manufactures targeted immunotherapeutics for the treatment of cancers and infectious diseases. Transgeneâs products are major technological breakthroughs. They use well tolerated viruses to indirectly or directly kill infected...
NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide⢠class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral dis...
ZymoGenetics is a biopharmaceutical company focused on the development and commercialization of therapeutic proteins for the treatment of human diseases. The company has developed and is marketing RECOTHROM® Thrombin, topical (Recombinant) in the United States. ZymoGenetics has two product candidates in Phase 2 clinical development: PEG-Interferon lambd...
IncellDx, Inc. is a molecular diagnostics company dedicated to revolutionizing healthcare one cell at a time. By combining molecular diagnostics with high throughput cellular analysis, we focus on critical life threatening diseases such as HIV/AIDS, HPV/Cervical Cancer, Hepatitis, organ transplant infections, breast cancer and ovarian cancer.
Regulus Therapeutics is a biopharmaceutical company leading the discovery and development of innovative new medicines based on microRNAs. Regulus is targeting microRNAs as a new class of therapeutics by working with a broad network of academic collaborators and leveraging oligonucleotide drug discovery and development expertise from its founding companies...
Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals, Inc., of Tarrytown, NY, is a biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Principal programs are directed toward supportive care, oncology and virology. Progeni...
Novelos Therapeutics, Inc. is a biopharmaceutical company commercializing oxidized glutathione-based compounds for the treatment of cancer and hepatitis. Novelos is seeking to build a pipeline through licensing or acquiring clinical stage compounds or technologies for oncology indications. Our lead compound, NOV-002, has been administered to approximately...
SciClone Pharmaceuticals, Inc.
SciClone Pharmaceuticals (NASDAQ: SCLN) is a profit-driven, global specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. SciClone is focused on continuing international sales growth, a cost-containing clinical development strategy, and overall expense manage...
Biota is a leading anti-infective drug development company based in Melbourne Australia, with key expertise in respiratory diseases, particularly influenza. Biota developed the first-in-class neuraminidase inhibitor, zanamivir, subsequently marketed by GlaxoSmithKline as Relenza. Biota research breakthroughs have included novel nucleoside analogues designe...
Lipid Sciences, Inc. (LIPD) is a development-stage biotechnology company that is researching and developing products and processes to treat major medical indications such as cardiovascular disease, HIV and other viral infections in which lipids or fat components play a key role. LIPD's technologies are based on a patented process that selectively and rapidly removes lipids from proteins circulatin...
We aim to develop novel technologies to provide safer and more effective options to patients in areas with substantial unmet medical needs, particularly in the areas of biosurgical and passive immunotherapy products. We are utilizing our proprietary protein purification technology, innovative development capabilities, and manufacturing know-how to develop these product lines, often through collabo...
Medivir develops drugs against major, widespread diseases, based on proteases as the target enzyme. Its objective is to be a sustainable and profitable research-based pharmaceutical company with products on the market that it has developed in-house. Medivir was founded in 1988.In Sweden, the company is located in Huddinge, near Stockholm, and in the UK, at Chesterford Research Park, Essex.The grou...
Triatomic Oxygen (O3 or ozone), is the first layer of atmospheric protection interfacing the vastness of the cosmos with Planet Earth. Ozone's healing properties have been known for many years and the use of medical ozone pre-dates WW I. Toxicity was a problem in early medical ozone usage as the drug was produced using compressed air containing nitrogen, rather than medical grade oxygen (O2). The...
Established in 1994, MedMira Laboratories is a public Canadian Life Sciences company exclusively focused on developing, manufacturing and marketing the next generation of easy-to-use rapid diagnostic tests. Today, MedMira is a recognized leader in providing rapid tests for the clinical laboratory market worldwide. MedMira’s tests detect markers in serum, plasma or whole blood for infectious...
Mister Test.com online shop! Welcome Guest! Would you like to log yourself in? Or would you prefer to create an account? Hi! We offer home tests: home drug tests, early home pregnancy tests, home ovulation tests - ovulation predictor kits, home alcohol tests, forensic tests, health and wellness, aromatherapy products, digital thermometer, blood pressure monitor, hemoglobin tests, hepatitis-c tes...
National Genetics Institute (NGI), a wholly owned subsidiary of Laboratory Corporation of America, provides advanced clinical testing services to the biopharmaceutical industry and medical providers utilizing sophisticated applied genetics techniques. NGI has developed industry-leading assays for human immunodeficiency virus (HIV), hepatitis viruses A, B, and C (HAV, HBV, and HCV) and other infec...
Peregrine Pharmaceuticals, Inc. (NASDAQ-PPHM) is a clinical stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection. The Company is advancing three separate clinical programs with its lead product candidates bavituximab and Cotara®. Bavituximab and Cotara are both in Phase II clinical studies for the treatment o...
Quest Clinical Research Developing new therapies for the treatment and prevention of viral illness including HIV/AIDS, Hepatitis B & C, Herpes Simplex, Human Papilloma Virus, CMV and Influenza
REPLICor Inc. is a biopharmaceutical company developing novel broad-spectrum antiviral drugs. Its lead compound, REP 9, is active against 12 viral families including influenza, hepatitis B and C, HIV, RSV and herpes. The company’s business strategy is to enter into an alliance with a major pharmaceutical company to further develop and market its technology.
Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2% of the shares of Rhein Biotech, in the year 2002. For more information on Berna Biotech please go to: http://www.bernabiotech.com/company/index.htmlRhein Biotech has been listed on the Frankfurt Sto...
